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Abstracts
CMS-06. THE NOPHO-EUROPEAN STUDY ON CEREBELLAR
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BACKGROUND: The cerebellar mutism syndrome (CMS) is one of the most
disabling late effects afterneurosurgery foraposterior fossa tumour inchildhood.
The reported incidences vary substantially in previous studies. AIMS:
Pathophysiology is unknown, but damage to cerebello-thalamo-cerebral circuits
is likely.Thestudyfocusesontheriskfactors fordevelopmentandseverityofCMS
including surgery (approaches, techniques and tissue and vascular damage, re-
operation) and host genome variants. METHODS: Multicentre study developed
as a NOPHO collaborative study coordinated from Righospitalet, Copenhagen
with online data registration and database management at Karolinska,
Stockholm and quarterly online participant meetings. Registration includes clin-
ical data and speech samples collected preoperatively and at four defined postop-
erative points for the subsequent 12 months. Therapy, including neurosurgery, is
by local standards. A blood sample for genetic analysis is collected from all pa-
tients. Imaging is collected and reviewed centrally. RESULTS: The study aims
to recruit 550 children. It opened in five Nordic and Baltic countries during
2014/2015; in the Netherlands in February 2016 and will open in the UK
during2016.Two Germancentreswill join in2017.The target accrualof550 pa-
tients will be reached by the end of 2018. As of February 2016, 67 patients have
been included from 12 centres. Mutism has occurred in 7 cases. CONCLUSION:
The study will be the largest prospective international study on CMS to date, and
the first one to 1) systematically register surgery, use of steroids, standardized
speech samples and 2) to investigate the influence of host genome.
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